Jamie Haney is Corporate Vice President and General Counsel at Novo
Nordisk Inc. starting with the company in August 2020. She is
responsible for leading Novo Nordisk's U.S. Legal organization. Under
her direction, this team of professionals provide legal counsel across
Novo Nordisk North America Operations. This includes providing
guidance in all commercial, enterprise and business development
activities and initiatives, directing litigation strategies and
mitigating risk and managing its intellectual property.
Ms. Haney has 13 years of corporate legal and healthcare
leadership experience in the pharmaceutical and private law sectors.
Before joining Novo Nordisk in 2020, she was Managing Director at
Eli Lilly Suisse, the company's Switzerland affiliate, where she was
responsible for all aspects of the +$100M business.
Prior to her role as Managing Director, Ms. Haney held diverse
positions across Eli Lilly’s legal and commercial units. For three
years, Jamie served as Assistant Corporate Secretary/Corporate
Securities and Antitrust Counsel where she advised leadership on
corporate governance and legal matters. She also held sales leadership
roles that involved the supervision of a national team of regional
market directors and regional market access representatives. Earlier
in her career she worked as an attorney at a leading international law
firm focusing on complex commercial securities and antitrust cases in
a range of industries including healthcare, consumer, and commercial products.
During her time in Switzerland, Jamie served on the Executive
Committee of Interpharma - the pharmaceutical trade association. She
is also an active advocate for diversity and inclusion and co-founded
the Leading Women in the Law Division ("WILD") at Lilly.
Ms. Haney is a member of the bar associations of Illinois and
Indiana. She holds a bachelor's degree in English from Purdue
University and earned her law degree from DePaul University College of
Law, graduating magna cum laude.